Welcome to LookChem.com Sign In|Join Free
  • or
3-Piperidinecarboxamide, N-[4-[(cyclohexylacetyl)amino]phenyl]-, monohydrochloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

878010-20-9

Post Buying Request

878010-20-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

878010-20-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 878010-20-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,0,1 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 878010-20:
(8*8)+(7*7)+(6*8)+(5*0)+(4*1)+(3*0)+(2*2)+(1*0)=169
169 % 10 = 9
So 878010-20-9 is a valid CAS Registry Number.

878010-20-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-(2-cyclohexylacetamido)-phenyl)-piperidine-3-carboxamide hydrochloride

1.2 Other means of identification

Product number -
Other names ENMD-1771

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:878010-20-9 SDS

878010-20-9Upstream product

878010-20-9Downstream Products

878010-20-9Relevant academic research and scientific papers

COMPOSITIONS AND METHODS COMPRISING PROTEINASE ACTIVATED RECEPTOR ANTAGONISTS

-

Page/Page column 103; 104, (2010/10/20)

Compositions and methods comprising proteinase activated receptor antagonists are provided. More particularly, the present invention relates to the use of proteins, peptides and molecules that bind to proteinase activated receptor 2, and inhibit the processes associated with the activation of that receptor. More specifically, the present invention provides novel compositions and methods for the treatment of disorders and diseases such as those associated with abnormal cellular proliferation, angiogenesis, inflammation and cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 878010-20-9